ClinicalTrials.govpublic full text
A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
infections, human immunodeficiency virus and herpesviridae, infection, human immunodeficiency virus, formulation, bioavailability, pharmacokinetics, gsk2248761, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908630
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.